Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-03-06

Clinical Trial Update: Does Nesiritide Provide Renal Protection [Phase 2]

View source ↗

Summary

Phase 2 trial assessed whether nesiritide provides renal protection in patients with renal failure; results were posted in March 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Natrecor (nesiritide)

Snippet

Sponsor: University of Florida | Conditions: Renal Failure | Phase 2 | Status: COMPLETED | Results posted: 2014-03-06